Danish medical cannabis program passes 2,000-patient mark
Denmark’s medical cannabis pilot program continues to show steady improvement, with the number of patients exceeding the 2,000 mark.
Denmark’s medical cannabis pilot program continues to show steady improvement, with the number of patients exceeding the 2,000 mark.
Ontario, Canada-based CannTrust Holdings reported that first-quarter revenue more than doubled from a year earlier, mostly on the back of rising medical marijuana sales, while the company’s net income inched higher.
Infused cannabis products won’t be widely distributed in Canada until 2020, according to one of the leading experts in the field – but businesses shouldn’t drag their feet on preparations.
With Europe fast becoming a cornerstone in the global medical marijuana industry, business leaders from dozens of countries descended on Copenhagen, Denmark, to discuss emerging opportunities in the burgeoning market.
The number of patients who received medical cannabis prescriptions in Denmark more than tripled in the initial year of the country’s program, exceeding expectations of executives in the country.
Marijuana Business Daily caught up with Rikke Jakobsen, CEO of Cannabis Denmark, a nongovernmental organization, to discuss the medical marijuana industry in Denmark and its global ambitions.